{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:21:58Z","timestamp":1793013718876,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","award":["HHSF-223-2018-10020I"],"award-info":[{"award-number":["HHSF-223-2018-10020I"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.vaccine.2025.127614","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:34:59Z","timestamp":1755822899000},"page":"127614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Safety monitoring of health outcomes following influenza vaccination during the 2023\u20132024 season among U.S. Commercially-insured individuals aged 6\u00a0months through 64\u00a0years: Self-controlled case series analyses"],"prefix":"10.1016","volume":"63","author":[{"given":"Patricia C.","family":"Lloyd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyanada","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Beachler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Secora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djeneba Audrey","family":"Djibo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandace L.","family":"Amend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derick","family":"Ambarsoomzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tainya C.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Parlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosenie","family":"Thelus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl N.","family":"McMahill-Walraven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruobing","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Parambi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa W.","family":"Tarazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoganand","family":"Chillarige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Forshee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127614_bb0005","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.vaccine.2025.127614_bb0010","author":"U.S. Food and Drug Administration"},{"key":"10.1016\/j.vaccine.2025.127614_bb0015","author":"U.S. Food and Drug Administration"},{"key":"10.1016\/j.vaccine.2025.127614_bb0020","author":"Centers for Disease Control and Prevention"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127614_bb0025","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1080\/21645515.2016.1182270","article-title":"Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: a phase III, double-blind, multicenter, randomized, non-inferiority study","volume":"12","author":"Bart","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127614_bb0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cid\/ciz202","article-title":"Safety of inactivated influenza vaccine in cancer patients receiving immune checkpoint inhibitors","volume":"70","author":"Chong","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"35","key":"10.1016\/j.vaccine.2025.127614_bb0035","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1016\/j.vaccine.2016.06.064","article-title":"Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: a systematic review and meta-analysis of randomised controlled trials","volume":"34","author":"Moa","year":"2016","journal-title":"Vaccine"},{"issue":"47","key":"10.1016\/j.vaccine.2025.127614_bb0040","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1016\/j.vaccine.2013.08.069","article-title":"Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults","volume":"31","author":"P\u00e9pin","year":"2013","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2025.127614_bb0045","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.vaccine.2016.03.048","article-title":"Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, vaccine adverse event reporting system (VAERS), July 1, 2013\u2212may 31, 2015","volume":"34","author":"Haber","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127614_bb0050","author":"Biologics Effectiveness and Safety (BEST) Initiative"},{"key":"10.1016\/j.vaccine.2025.127614_bb0055","series-title":"Assessment of COVID-19 and mpox vaccine data when supplementing administrative claims with immunization information system data. International Society of Pharamacoepidemiology (ISPE) meeting; Halifax, Nova Scotia, Canada","author":"Stockbower","year":"2023"},{"key":"10.1016\/j.vaccine.2025.127614_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127069","article-title":"Safety monitoring of health outcomes following influenza vaccination during the 2023\u20132024 season among U.S. Medicare beneficiaries aged 65 years and older","volume":"53","author":"Lloyd","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127614_bb0065","author":"Biologics Effectiveness and Safety (BEST) Initiative"},{"key":"10.1016\/j.vaccine.2025.127614_bb0070","article-title":"Self controlled case series methods: an alternative to standard epidemiological study designs","volume":"354","author":"Petersen","year":"2016","journal-title":"BMJ"},{"issue":"31","key":"10.1016\/j.vaccine.2025.127614_bb0075","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"R\u00fcggeberg","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127614_bb0080","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jaci.2018.12.1003","article-title":"Anaphylaxis after vaccination reported to the vaccine adverse event reporting system, 1990-2016","volume":"143","author":"Su","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127614_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077766","article-title":"Acute disseminated encephalomyelitis onset: evaluation based on vaccine adverse events reporting systems","volume":"8","author":"Pellegrino","year":"2013","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.vaccine.2025.127614_bb0090","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1177\/0961203309345730","article-title":"Transverse myelitis and vaccines: a multi-analysis","volume":"18","author":"Agmon-Levin","year":"2009","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127614_bb0095","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0320","article-title":"Febrile seizure risk after vaccination in children 6 to 23 months","volume":"138","author":"Duffy","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2025.127614_bb0100","article-title":"Stroke after vaccination in United States. A report from the CDC\/FDA vaccine adverse event reporting system. [1990\u20132010] (P01.009)","volume":"78","author":"Qudah","year":"2012"},{"issue":"25","key":"10.1016\/j.vaccine.2025.127614_bb0105","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1056\/NEJMoa041747","article-title":"Risk of myocardial infarction and stroke after acute infection or vaccination","volume":"351","author":"Smeeth","year":"2004","journal-title":"N Engl J Med"},{"issue":"40","key":"10.1016\/j.vaccine.2025.127614_bb0110","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1016\/j.vaccine.2013.06.032","article-title":"International collaboration to assess the risk of Guillain Barr\u00e9 syndrome following influenza a (H1N1) 2009 monovalent vaccines","volume":"31","author":"Dodd","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127614_bb0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2025.127614_bb0120","author":"United States (U.S.) Department of Health and Human Services (DHHS)"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127614_bb0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amepre.2011.04.004","article-title":"H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project","volume":"41","author":"Lee","year":"2011","journal-title":"Am J Prev Med"},{"issue":"41","key":"10.1016\/j.vaccine.2025.127614_bb0130","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1016\/j.vaccine.2015.08.013","article-title":"Influenza vaccination and risk of stroke: self-controlled case-series study","volume":"33","author":"Asghar","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127614_bb0135","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s12879-015-1263-7","article-title":"Febrile seizures after 2009 influenza a (H1N1) vaccination and infection: a nationwide registry-based study","volume":"15","author":"Bakken","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127614_bb0140","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.vaccine.2011.12.042","article-title":"Febrile seizures after 2010-2011 influenza vaccine in young children, United States: a vaccine safety signal from the vaccine adverse event reporting system","volume":"30","author":"Leroy","year":"2012","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127614_bb0145","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1586\/14760584.2013.814781","article-title":"Vaccines and febrile seizures","volume":"12","author":"Principi","year":"2013","journal-title":"Expert Rev Vaccines"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127614_bb0150","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.vaccine.2020.01.046","article-title":"The risk of febrile seizures following influenza and 13-valent pneumococcal conjugate vaccines","volume":"38","author":"Baker","year":"2020","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127614_bb0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1747493018816430","article-title":"How do neurologists diagnose transient ischemic attack: a systematic review","volume":"14","author":"Fitzpatrick","year":"2019","journal-title":"Int J Stroke\u202f: Off J Int Stroke Soc"},{"key":"10.1016\/j.vaccine.2025.127614_bb0160","article-title":"Influenza vaccine effect on risk of stroke occurrence: a systematic review and meta-analysis","volume":"14","author":"Zahhar","year":"2023","journal-title":"Front Neurol"},{"issue":"19","key":"10.1016\/j.vaccine.2025.127614_bb0165","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000201123","article-title":"Influenza vaccination and risk of ischemic stroke","volume":"99","author":"Rodr\u00edguez-Mart\u00edn","year":"2022","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127614_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-2667(22)00222-5","article-title":"Association between influenza vaccination and risk of stroke in Alberta, Canada: a population-based study","volume":"7","author":"Holodinsky","year":"2022","journal-title":"Lancet Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25009119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25009119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T03:54:37Z","timestamp":1765857277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25009119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":34,"alternative-id":["S0264410X25009119"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127614","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety monitoring of health outcomes following influenza vaccination during the 2023\u20132024 season among U.S. Commercially-insured individuals aged 6\u00a0months through 64\u00a0years: Self-controlled case series analyses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127614"}}